Thromb Haemost 1981; 46(01): 274
DOI: 10.1055/s-0038-1652817
Prostaglandins – IV
Schattauer GmbH Stuttgart

Prostaglandins And Uterine Bleeding

C F Goodfellow
University Departments of Medicine and Obstetrics, Leeds, and Wellcome Research Laboratories, Beckenham, U.K
,
R C Paton
University Departments of Medicine and Obstetrics, Leeds, and Wellcome Research Laboratories, Beckenham, U.K
,
S Moncada
University Departments of Medicine and Obstetrics, Leeds, and Wellcome Research Laboratories, Beckenham, U.K
,
J A Salmon
University Departments of Medicine and Obstetrics, Leeds, and Wellcome Research Laboratories, Beckenham, U.K
,
J A Davies
University Departments of Medicine and Obstetrics, Leeds, and Wellcome Research Laboratories, Beckenham, U.K
,
G P McNicol
University Departments of Medicine and Obstetrics, Leeds, and Wellcome Research Laboratories, Beckenham, U.K
› Author Affiliations
Further Information

Publication History

Publication Date:
26 July 2018 (online)

There is little information about haemostatic function in the uterus in relation to menstrual bleeding. We measured platelet count and platelet retention in glass-bead columns, and plasma levels of FPA, TxB2 and 6-oxo-PGF in samples taken simultaneously from uterine vein (UV) and peripheral vein (PV) in 18 women (2 post-menopausal) undergoing hysterectomy. Platelet counts and FPA concentrations were similar in both sets of samples. Plasma levels of 6-oxo- PGF were significantly (p<0.01) higher in UV (1.34 ± 1.27 ng/ml, mean ± SD) than in PV (0.18 ± 0.39 ng/ml) as were levels of TxB2 (0.46 ± 0.54 and 0.1 ± 0.13 ng/ml). Platelet retention in UV blood was about half that observed in PV blood and the degree of platelet retention correlated inversely with plasma concentration of 6-oxo-PGF (r = -0.48, p<0.01). There was a highly significant (p<0.01) rank order between the time since menstruation and plasma 6-oxo-PGF concentration in UV blood. TxB2 levels were highest on day 4 and then fell suddenly with time since menstruation. The results indicate that prostaglandins may modulate uterine bleeding at menstruation. Release of PGI2 from uterine vessels could contribute to the lack of platelet deposition in the menstruating uterus and by this mechanism to the persistence of menstrual bleeding.